Analysts Set Expectations for Humana Inc.’s FY2018 Earnings (HUM)

Humana Inc. (NYSE:HUM) – Equities research analysts at Cantor Fitzgerald issued their FY2018 earnings per share (EPS) estimates for Humana in a note issued to investors on Friday. Cantor Fitzgerald analyst S. Halper anticipates that the insurance provider will post earnings of $11.50 per share for the year. Cantor Fitzgerald currently has a “Neutral” rating on the stock.

Other equities research analysts have also recently issued reports about the stock. Cowen and Company reissued an “outperform” rating and issued a $230.00 price target on shares of Humana in a research report on Tuesday, April 25th. Zacks Investment Research raised shares of Humana from a “hold” rating to a “buy” rating and set a $257.00 price target for the company in a research report on Thursday, May 25th. Leerink Swann boosted their price target on shares of Humana from $250.00 to $265.00 and gave the company an “outperform” rating in a research report on Tuesday, May 30th. BidaskClub cut shares of Humana from a “buy” rating to a “hold” rating in a research report on Tuesday, June 13th. Finally, Citigroup Inc. assumed coverage on shares of Humana in a research report on Wednesday. They issued a “buy” rating and a $275.00 price target for the company. Eight equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $225.75.

COPYRIGHT VIOLATION NOTICE: This report was published by Stock Observer and is the sole property of of Stock Observer. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The correct version of this report can be accessed at https://www.thestockobserver.com/2017/07/18/analysts-set-expectations-for-humana-inc-s-fy2018-earnings-hum-updated-updated.html.

Shares of Humana (HUM) traded up 1.22% on Monday, reaching $239.55. The company had a trading volume of 572,659 shares. The stock has a market capitalization of $34.57 billion, a P/E ratio of 24.41 and a beta of 0.90. The company’s 50 day moving average price is $230.72 and its 200-day moving average price is $213.63. Humana has a 1-year low of $150.00 and a 1-year high of $240.48.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, May 3rd. The insurance provider reported $2.75 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.55 by $0.20. Humana had a return on equity of 14.38% and a net margin of 2.71%. The company had revenue of $13.76 billion for the quarter, compared to analysts’ expectations of $13.61 billion. During the same quarter in the prior year, the firm earned $1.86 earnings per share.

The company also recently declared a quarterly dividend, which will be paid on Monday, July 31st. Stockholders of record on Friday, June 30th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Wednesday, June 28th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.67%. Humana’s dividend payout ratio (DPR) is 16.24%.

In other Humana news, SVP Jody L. Bilney sold 4,600 shares of the company’s stock in a transaction dated Friday, May 5th. The shares were sold at an average price of $230.16, for a total transaction of $1,058,736.00. Following the transaction, the senior vice president now directly owns 8,978 shares in the company, valued at $2,066,376.48. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, VP Timothy S. Huval sold 13,939 shares of the company’s stock in a transaction dated Thursday, May 4th. The stock was sold at an average price of $225.86, for a total transaction of $3,148,262.54. Following the transaction, the vice president now owns 23,639 shares in the company, valued at $5,339,104.54. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 138,270 shares of company stock worth $31,253,863. Company insiders own 0.80% of the company’s stock.

A number of hedge funds and other institutional investors have recently modified their holdings of HUM. Guardian Life Insurance Co. of America raised its position in shares of Humana by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock valued at $119,000 after buying an additional 4 shares during the last quarter. Point72 Asia Hong Kong Ltd bought a new position in shares of Humana during the first quarter valued at $128,000. MUFG Americas Holdings Corp bought a new position in shares of Humana during the first quarter valued at $221,000. Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Humana during the first quarter valued at $223,000. Finally, Nikko Asset Management Americas Inc. bought a new position in shares of Humana during the first quarter valued at $227,000. Institutional investors own 98.92% of the company’s stock.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Earnings History and Estimates for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply